The effect of enterovirus 71 immunization on neuropathogenesis and protein expression profiles in the thalamus of infected rhesus neonates

Virology

Volumn 432, Issue 2, 2012, Pages 417-426

  Chen, Huicheng ^a,b   Zhang, Ying ^a   Yang, Erxia ^a   Liu, Longding ^a   Che, Yanchun ^a   Wang, Jingjing ^a   Zhao, Hongling ^a   Tang, Donghong ^a   Dong, Chenghong ^a   Yang, Lixian ^a   Shen, Dong ^a   Wang, Xi ^a   Liao, Yun ^a   Wang, Lichun ^a   Na, Ruixiong ^a   Liang, Yan ^a   Li, Qihan ^a  

^a INSTITUTE OF MEDICAL BIOLOGY   (China)

^b YUNNAN UNIVERSITY   (China)

Author keywords

Enterovirus 71 (EV71); Expression profiles; Inactivated virus vaccines; Neonatal rhesus monkeys; Neuropathogenesis; Thalamus

Indexed keywords

ENTEROVIRUS 71 VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENTEROVIRUS 71; ENTEROVIRUS INFECTION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; MALE; MOLECULAR MECHANICS; NEUROPATHOLOGY; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; THALAMUS; VIRUS PATHOGENESIS;

ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, VIRAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; GENE EXPRESSION PROFILING; IMMUNIZATION; INFLAMMATION; MACACA MULATTA; NERVOUS SYSTEM; THALAMUS; VACCINES, INACTIVATED; VIRAL VACCINES;

ANIMALIA; HUMAN ENTEROVIRUS 71; MACACA MULATTA;

EID: 84865285931     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.06.026     Document Type: Article

References (46)

1. Abou-Sleiman P.M., Muqit M.M., Wood N.W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 2006, 7(3):207-219.
2. Arita M., Nagata N., Sata T., Miyamura T., Shimizu H. Quantitative analysis of poliomyelitis-like paralysis in mice induced by a poliovirus replicon. J. Gen. Virol. 2006, 87(Pt 11):3317-3327.
3. Arora K., Gwinn W.M., Bower M.A., Watson A., Okwumabua I., MacDonald H.R., Bukrinsky M.I., Constant S.L. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J. Immunol. 2005, 175(1):517-522.
4. Bandopadhyay R., Kingsbury A.E., Cookson M.R., Reid A.R., Evans I.M., Hope A.D., Pittman A.M., Lashley T., Canet-Aviles R., Miller D.W., McLendon C., Strand C., Leonard A.J., Abou-Sleiman P.M., Healy D.G., Ariga H., Wood N.W., de Silva R., Revesz T., Hardy J.A., Lees A.J. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease. Brain 2004, 127(Pt 2):420-430.
5. Camby I., Le Mercier M., Lefranc F., Kiss R. Galectin-1: a small protein with major functions. Glycobiology 2006, 16(11):137R-157R.
6. Ch'ng W.C., Stanbridge E.J., Ong K.C., Wong K.T., Yusoff K., Shafee N. Partial protection against enterovirus 71 (EV71) infection in a mouse model immunized with recombinant Newcastle disease virus capsids displaying the EV71 VP1 fragment. J. Med. Virol. 2011, 83(10):1783-1791.
7. Chan L.G., Parashar U.D., Lye M.S., Ong F.G., Zaki S.R., Alexander J.P., Ho K.K., Han L.L., Pallansch M.A., Suleiman A.B., Jegathesan M., Anderson L.J. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin. Infect. Dis. 2000, 31(3):678-683.
8. Chang L.Y., Hsiung C.A., Lu C.Y., Lin T.Y., Huang F.Y., Lai Y.H., Chiang Y.P., Chiang B.L., Lee C.Y., Huang L.M. Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr. Res. 2006, 60(4):466-471.
9. Chen S.C., Chang H.L., Yan T.R., Cheng Y.T., Chen K.T. An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. Am. J. Trop. Med. Hyg. 2007, 77(1):188-191.
10. Dong C., Liu L., Zhao H., Wang J., Liao Y., Zhang X., Na R., Liang Y., Wang L., Li Q. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine 2011, 29(37):6269-6275.
11. Dong C., Wang J., Liu L., Zhao H., Shi H., Zhang Y., Jiang L., Li Q. Optimized development of a candidate strain of inactivated EV71 vaccine and analysis of its immunogenicity in rhesus monkeys. Hum. Vaccine 2010, 6(12):1028-1037.
12. Gorska P. Principles in laboratory animal research for experimental purposes. Med. Sci. Monit. 2000, 6(1):171-180.
13. Guo R., Cao Y., Dai Z., Qu S., Zhuang J. Characteristics of a human diploid cell strain KMB-17. Acta Acad. Med. Sin. 1981, 3(4):226-230.
14. Han J.F., Cao R.Y., Deng Y.Q., Tian X., Jiang T., Qin E.D., Qin C.F. Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol. J. 2011, 8:106.
15. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999, 341(13):929-935.
16. Hsueh C., Jung S.M., Shih S.R., Kuo T.T., Shieh W.J., Zaki S., Lin T.Y., Chang L.Y., Ning H.C., Yen D.C. Acute encephalomyelitis during an outbreak of enterovirus type 71 infection in Taiwan: report of an autopsy case with pathologic, immunofluorescence, and molecular studies. Mod. Pathol. 2000, 13(11):1200-1205.
17. Huang M.C., Wang S.M., Hsu Y.W., Lin H.C., Chi C.Y., Liu C.C. Long-term cognitive and motor deficits after enterovirus 71 brainstem encephalitis in children. Pediatrics 2006, 118(6):e1785-e1788.
18. Huang S.C., Chang C.L., Wang P.S., Tsai Y., Liu H.S. Enterovirus 71-induced autophagy detected in vitro and in vivo promotes viral replication. J. Med. Virol. 2009, 81(7):1241-1252.
19. Inden M., Taira T., Kitamura Y., Yanagida T., Tsuchiya D., Takata K., Yanagisawa D., Nishimura K., Taniguchi T., Kiso Y., Yoshimoto K., Agatsuma T., Koide-Yoshida S., Iguchi-Ariga S.M., Shimohama S., Ariga H. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Neurobiol. Dis. 2006, 24(1):144-158.
20. Kung C.M., King C.C., Lee C.N., Huang L.M., Lee P.I., Kao C.L. Differences in replication capacity between enterovirus 71 isolates obtained from patients with encephalitis and those obtained from patients with herpangina in Taiwan. J. Med. Virol. 2007, 79(1):60-68.
21. Lin M.T., Wang J.K., Lu F.L., Wu E.T., Yeh S.J., Lee W.L., Wu J.M., Wu M.H. Heart rate variability monitoring in the detection of central nervous system complications in children with enterovirus infection. J. Crit. Care 2006, 21(3):280-286.
22. Lin T.Y., Chang L.Y., Huang Y.C., Hsu K.H., Chiu C.H., Yang K.D. Different proinflammatory reactions in fatal and non-fatal enterovirus 71 infections: implications for early recognition and therapy. Acta Paediatr. 2002, 91(6):632-635.
23. Lin T.Y., Hsia S.H., Huang Y.C., Wu C.T., Chang L.Y. Proinflammatory cytokine reactions in enterovirus 71 infections of the central nervous system. Clin. Infect. Dis. 2003, 36(3):269-274.
24. Liu C.C., Tseng H.W., Wang S.M., Wang J.R., Su I.J. An outbreak of enterovirus 71 infection in Taiwan, 1998: epidemiologic and clinical manifestations. J. Clin. Virol. 2000, 17(1):23-30.
25. Liu L., Zhao H., Zhang Y., Wang J., Che Y., Dong C., Zhang X., Na R., Shi H., Jiang L., Wang L., Xie Z., Cui P., Xiong X., Liao Y., Zhao S., Gao J., Tang D., Li Q. Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection. Virology 2011, 412(1):91-100.
26. Liu Y., Fallon L., Lashuel H.A., Liu Z., Lansbury P.T. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 2002, 111(2):209-218.
27. Lum L.C., Wong K.T., Lam S.K., Chua K.B., Goh A.Y., Lim W.L., Ong B.B., Paul G., AbuBakar S., Lambert M. Fatal enterovirus 71 encephalomyelitis. J. Pediatr. 1998, 133(6):795-798.
28. Ma S.-h., Liu J.-s., Wang J.-j., Shi H.-j., Yang H.-j., Chen J.-y., Liu L-d., Li Q.-h. Genetic Analysis of the VP1 Region of Human Enterovirus 71 Strains Isolated in Fuyang, China, During 2008. Virol. Sin. 2009, 24(3):162-170.
29. McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002, 26(1):91-107.
30. Nagata N., Iwasaki T., Ami Y., Tano Y., Harashima A., Suzaki Y., Sato Y., Hasegawa H., Sata T., Miyamura T., Shimizu H. Differential localization of neurons susceptible to enterovirus 71 and poliovirus type 1 in the central nervous system of cynomolgus monkeys after intravenous inoculation. J. Gen. Virol. 2004, 85(Pt 10):2981-2989.
31. Nolan M.A., Craig M.E., Lahra M.M., Rawlinson W.D., Prager P.C., Williams G.D., Bye A.M., Andrews P.I. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 2003, 60(10):1651-1656.
32. Ooi M.H., Solomon T., Podin Y., Mohan A., Akin W., Yusuf M.A., del Sel S., Kontol K.M., Lai B.F., Clear D., Chieng C.H., Blake E., Perera D., Wong S.C., Cardosa J. Evaluation of different clinical sample types in diagnosis of human enterovirus 71-associated hand-foot-and-mouth disease. J. Clin. Microbiol. 2007, 45(6):1858-1866.
33. Ren W.Z., Ng G.Y., Wang R.X., Wu P.H., O'Dowd B.F., Osmond D.H., George S.R., Liew C.C. The identification of NP25: a novel protein that is differentially expressed by neuronal subpopulations. Brain Res. Mol. Brain Res. 1994, 22(1-4):173-185.
34. Shaw P., Bovey R., Tardy S., Sahli R., Sordat B., Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. U S A 1992, 89(10):4495-4499.
35. Shimizu H., Utama A., Yoshii K., Yoshida H., Yoneyama T., Sinniah M., Yusof M.A., Okuno Y., Okabe N., Shih S.R., Chen H.Y., Wang G.R., Kao C.L., Chang K.S., Miyamura T., Hagiwara A. Enterovirus 71 from fatal and nonfatal cases of hand, foot and mouth disease epidemics in Malaysia, Japan and Taiwan in 1997-1998. Jpn. J. Infect. Dis. 1999, 52(1):12-15.
36. Takahashi K., Taira T., Niki T., Seino C., Iguchi-Ariga S.M., Ariga H. DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor. J. Biol. Chem. 2001, 276(40):37556-37563.
37. Wang S.M., Chen I.C., Su L.Y., Huang K.J., Lei H.Y., Liu C.C. Enterovirus 71 infection of monocytes with antibody-dependent enhancement. Clin. Vaccine Immunol. 2010, 17(10):1517-1523.
38. Wang S.M., Lei H.Y., Huang K.J., Wu J.M., Wang J.R., Yu C.K., Su I.J., Liu C.C. Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema. J. Infect. Dis. 2003, 188(4):564-570.
39. Wessel D., Flugge U.I. A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids. Anal. Biochem. 1984, 138(1):141-143.
40. Wong K.T., Munisamy B., Ong K.C., Kojima H., Noriyo N., Chua K.B., Ong B.B., Nagashima K. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 2008, 67(2):162-169.
41. Xie Z., Long R., Li H., Chen H., Song X., Huang K., Hong C., Yang R., Bai H. The study of detection methods and application of the relative potency in vitro of inactivated Hepatitis A vaccine (chinese). J. Med. Res. 2010, 39(1):50-52.
42. Yanagida T., Takata K., Inden M., Kitamura Y., Taniguchi T., Yoshimoto K., Taira T., Ariga H. Distribution of DJ-1, Parkinson's disease-related protein PARK7, and its alteration in 6-hydroxydopamine-treated hemiparkinsonian rat brain. J. Pharmacol. Sci. 2006, 102(2):243-247.
43. Yang F., Ren L., Xiong Z., Li J., Xiao Y., Zhao R., He Y., Bu G., Zhou S., Wang J., Qi J. Enterovirus 71 outbreak in the People's Republic of China in 2008. J. Clin. Microbiol. 2009, 47(7):2351-2352.
44. Yang F., Shi P., Xi X., Yi S., Li H., Sun Q., Sun M. Recombinant adenoviruses expressing TRAIL demonstrate antitumor effects on non-small cell lung cancer (NSCLC). Med. Oncol. 2006, 23(2):191-204.
45. Zhang Y., Cui W., Liu L., Wang J., Zhao H., Liao Y., Na R., Dong C., Wang L., Xie Z., Gao J., Cui P., Zhang X., Li Q. Pathogenesis study of enterovirus 71 infection in rhesus monkeys. Lab. Invest. 2011, 91(9):1337-1350.
46. Zimmerman R.D. MR imaging findings of enteroviral encephalomyelitis: an outbreak in Taiwan. AJNR Am. J. Neuroradiol. 1999, 20(10):1775-1776.